Three Firms Aim To Launch Therapies For Hereditary Angioedema In 2008

Lev, which submitted a BLA in July, is vying with Dyax and German firm Jerini to launch drugs next year.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet